UMECLIDINIUM/VILANTEROL DISK INHALER - ORAL

  • Home
  • UMECLIDINIUM/VILANTEROL DISK INHALER - ORAL

UMECLIDINIUM/VILANTEROL DISK INHALER - ORAL

PHONETIC PRONUNCIATION: (ue-ME-kli-DIN-ee-um/vye-LAN-ter-ol)

COMMON BRAND NAME(S): Anoro Ellipta

GENERIC NAME(S): umeclidinium bromide/vilanterol trifenatate

Uses

USES: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: umeclidinium and vilanterol. Both drugs work by relaxing the muscles around the airways in the lungs so they open up to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics, and vilanterol is a LABA medication (see also Warning section). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. This medication is not approved to treat asthma.


How to use UMECLIDINIUM/VILANTEROL DISK INHALER - ORAL

HOW TO USE: Read the Medication Guide and the product instructions provided by your pharmacist before you start using this medication and each time you get a refill. If you have any questions, ask your doctor or pharmacist. Inhale this medication by mouth as directed by your doctor, usually once daily. Do not open the cover of the inhaler until you are ready to use it. Each time you open the cover, you prepare a dose of the medication. If you open and close the cover without inhaling the medication, you will lose the dose. To avoid wasting a dose, do not close the cover until after you have inhaled the medication. You may or may not taste/feel the drug when you inhale. Do not exhale into the device. Use this medication regularly to get the most benefit from it. Use it at the same time every day. Do not use it more than one time each day. Do not increase your dose, use this medication more often, or stop using it without first consulting your doctor. Your condition will not improve any faster, and your risk of side effects will increase. If you are using other inhalers at the same time, wait at least 1 minute between the use of each medication. If you have been using a quick-relief inhaler (such as albuterol, also called salbutamol in some countries) on a regular daily schedule (such as 4 times daily), you must stop this schedule and only use the quick-relief inhaler as needed for sudden shortness of breath. Consult your doctor for details. Learn which of your inhalers you should use every day and which you should use if your breathing suddenly worsens (quick-relief drugs). Ask your doctor ahead of time what you should do if you have new or worsening cough or shortness of breath, wheezing, increased sputum, waking up at night with trouble breathing, if you use your quick-relief inhaler more often, or if your quick-relief inhaler does not seem to be working well. Learn when you can treat sudden breathing problems by yourself and when you must get medical help right away. Tell your doctor if your condition does not improve or if it worsens.

Side Effects

SIDE EFFECTS: Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. Tell your doctor right away if you have any serious side effects, including: shaking (tremor), nervousness, difficult/painful urination, muscle cramps/weakness, increased thirst/urination. This medication may raise your blood pressure. Check your blood pressure regularly and tell your doctor if the results are high. Infrequently, this medication may cause sudden, severe wheezing/trouble breathing immediately after you use it. If this happens, use your quick-relief inhaler and get medical help right away. Get medical help right away if you have any very serious side effects, including: chest pain, fast/irregular heartbeat, severe dizziness, fainting, eye pain/swelling/redness, vision changes (such as seeing rainbows around lights at night, blurred vision). A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

Precautions

PRECAUTIONS: Before using umeclidinium/vilanterol, tell your doctor or pharmacist if you are allergic to either drug, or if you have any other allergies. This product may contain inactive ingredients (such as milk proteins), which can cause allergic reactions or other problems. Talk to your pharmacist for more details. Before using this medication, tell your doctor or pharmacist your medical history, especially of: heart problems (such as chest pain, irregular heartbeat), high blood pressure, seizures, overactive thyroid, diabetes, personal or family history of glaucoma (angle-closure type), difficulty urinating (such as due to an enlarged prostate). Umeclidinium/vilanterol may cause a condition that affects the heart rhythm (QT prolongation). QT prolongation can rarely cause serious (rarely fatal) fast/irregular heartbeat and other symptoms (such as severe dizziness, fainting) that need medical attention right away. The risk of QT prolongation may be increased if you have certain medical conditions or are taking other drugs that may cause QT prolongation. Before using umeclidinium/vilanterol, tell your doctor or pharmacist of all the drugs you take and if you have any of the following conditions: certain heart problems (heart failure, slow heartbeat, QT prolongation in the EKG), family history of certain heart problems (QT prolongation in the EKG, sudden cardiac death). Low levels of potassium or magnesium in the blood may also increase your risk of QT prolongation. This risk may increase if you use certain drugs (such as diuretics/"water pills") or if you have conditions such as severe sweating, diarrhea, or vomiting. Talk to your doctor about using umeclidinium/vilanterol safely. Before having surgery, tell your doctor or dentist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products). Older adults may be more sensitive to the side effects of this drug, especially QT prolongation (see above). During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor. It is unknown if this medication passes into breast milk. Consult your doctor before breast-feeding.

Interactions

DRUG INTERACTIONS: Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor's approval. Do not use other anticholinergic drugs (such as ipratropium, tiotropium) or LABA drugs (such as formoterol, salmeterol) while using this medication.

Overdose

OVERDOSE: If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center. Symptoms of overdose may include: shaking (tremor), chest pain, fast/irregular heartbeat, seizures.

Reviews

No Reviews Yet


Faq for UMECLIDINIUM/VILANTEROL DISK INHALER - ORAL

Umeclidinium/Vilanterol Disk Inhaler is used to manage and prevent symptoms of asthma and COPD, such as wheezing, shortness of breath, and chest tightness.

Umeclidinium is an anticholinergic drug that helps relax the muscles around the airways, allowing for easier breathing. Vilanterol, on the other hand, is a long-acting beta agonist (LABA) that helps open up the air passages by relaxing the muscles in the airways.

Follow the instructions provided by your healthcare provider or the medication packaging. Usually, the inhaler is used once daily. Rinse your mouth with water after inhalation to prevent any potential side effects.

Common side effects may include cough, headache, throat irritation, and upper respiratory tract infection. Seek medical attention if you experience severe side effects such as chest pain, rapid heartbeat, or allergic reactions (rash, itching, swelling, severe dizziness).

You should discuss this with your healthcare provider. While there is limited data available, it is generally recommended to avoid using Umeclidinium/Vilanterol Disk Inhaler during pregnancy unless the potential benefits outweigh the risks. It is unknown if the medication passes into breast milk, so consult your doctor if you are breastfeeding.

Inform your doctor about all the medications you are taking, including prescription, over-the-counter (OTC), vitamins, and herbal supplements. Some drugs may interact with Umeclidinium/Vilanterol Disk Inhaler, so it is essential to provide a comprehensive list to your healthcare provider.

UMECLIDINIUM/VILANTEROL DISK INHALER - ORAL Pricing Page Get Discount Coupon

Warning

WARNING: One ingredient in this product is vilanterol. It belongs to the class of drugs known as long-acting beta agonists (LABAs). Rarely, people with asthma who use LABA medications have had serious (sometimes fatal) asthma-related breathing problems. Umeclidinium/vilanterol is not approved to treat asthma.


Disclaimer

IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.